Article

Valores de referencia del hemograma en embarazadas, con tecnología actual

Bioquímica y Patología Clínica 01/2007;
Source: DOAJ

ABSTRACT Se procesaron 435 muestras de embarazadas clínicamente sanas con la finalidad de obtener valores hematológicos de referencia utilizando un contador con tecnología actual. Los resultados, media y desvío estándar de cada parámetro hallado, se presentan agrupados por trimestres de gestación, lo cual permite observar las variaciones a lo largo del embarazo. Han sido significativos la disminución de hemoglobina y el aumento de leucocitos a expensas de neutrófilos y monocitos. Cualquier mínimo cambio en los valores hematimétricos de una embarazada, fuera de lo esperado fisiológicamente para cada trimestre, debe ser considerado en cuanto a magnitud y tiempo de gesta. Esto puede sugerir la presencia de alguna patología.

0 Bookmarks
 · 
657 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: The purpose of this longitudinal, prospective study was to define platelet indices during normal pregnancy and to compare them to normal nonpregnant values. Indices evaluated included platelet count, mean platelet volume, and platelet distribution width. No significant change occurred in the mean platelet count or mean platelet volume from the second to the third trimester; however, platelet distribution width increased progressively and significantly during this interval (p less than 0.0001). Mean platelet volume versus platelet count showed a significant inverse relationship (p less than 0.0001) and was congruent with normal nonpregnant values. Mean platelet volume versus platelet distribution width exhibited a significant direct relationship (p less than 0.03) that differed remarkably from normal nonpregnant values. These data support the concept of normal pregnancy as a compensated state of progressive platelet consumption. These findings may have important diagnostic and prognostic applications in discerning acute states of platelet consumption superimposed on the compensated consumption of normal pregnancy.
    American Journal of Obstetrics and Gynecology 05/1986; 154(4):883-7. · 3.88 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: To determine the prevalence of anemia during pregnancy in Venezuelan pregnant women. By using a cross-sectional study, 630 Venezuelan pregnant women in their third trimester at labor from the Valencia Anemia during Pregnancy Study were studied. Anemia during pregnancy was defined according to WHO guidelines (Hb < 11 g/dl), iron deficiency was considered when serum ferritin level was < 12 ng/ml, and when serum folate level was < 3 ng/ml, it was considered as folate deficiency. 630 pregnant women (mean [+/- SD] age, 24 +/- 6.4 years) having an average of Hb 11.38 +/- 1.47 g/dl [95%CI = 11.27 to 11.50] were studied. No patient had hemolytic anemia nor clinical infections. Almost all patients were from low or very low socioeconomic status. Prevalence of anemia was 34.44% (severe: 1.8%, moderate: 15.2%, and mild: 83%). Iron deficiency anemia (IDA) was present in 39.2% (95%CI = 32.7 to 45.7), prevalence of folate deficiency anemia (FDA) was 11.98% (95%CI = 7.6% to 16.3%). Combined anemia (IDA and FDA) occurred in 11.52% (95%CI = 7.27% to 15.7%). Multivariate analysis showed that multiparous (odds ratio -OR-: 1.95, 95%CI = 1.28 to 2.97, p = .002) and supplement use of iron (OR: .55 (95%CI = .33 to .91, p = .02) are associated with IDA. The factors associated with FDA were: supplement use of folic acid (OR: .37 (95%CI = .19 to .71, p = .003) and appropriate prenatal control (OR: .51 95%CI = .27 to .96, p = .04). Prevalence of anemia during pregnancy was found to be high. Educational efforts should be stressed in order to encourage improvements in the prenatal care visits.
    Archivos latinoamericanos de nutrición 04/2002; 52(1):5-11. · 0.24 Impact Factor
  • Source
    01/1987;

Full-text

Download
18 Downloads
Available from